Aquinnah Pharmaceuticals Inc.
Small-molecule inhibitors of tau stress granule formation for Alzheimer's disease treatment
- Sector
- Biotech
- Headquarters
- Newton, MA
- Total capital
- $17.1M
- Federal grants
- $17.1M
- 13 awards · 2015–2025
- Rank in peer group#104 of 514
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 27 pending · first 2023
- Rank in peer group#186 of 514
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Development of a novel Alzheimer's disease therapeutic targeting tau$999K
- Federal grantHealth and Human S · Phase II · Development of a novel oral brain penetrant therapeutic for ALS disease$1.5M
- Federal grantHealth and Human S · Phase II · Development of a novel Alzheimer's disease therapeutic targeting tau$1.0M
- Federal grantHealth and Human S · Phase II · Targeting tau for the development of novel Alzheimer's disease therapeutics$1M
- Federal grantHealth and Human S · Phase II · Targeting tau for the development of novel Alzheimer's disease therapeutics$2.5M
- Federal grantHealth and Human S · Phase II · Targeting tau for the development of novel Alzheimer's disease therapeutics$1.5M
- Federal grantHealth and Human S · Phase II · TDP-43 aggregation inhibitors for the treatment of ALS$2.5M
Show 6 earlier federal awards
- Federal grantHealth and Human S · Phase I · Tau/TIA1 aggregation inhibitors for the treatment of AD$379K
- Federal grantHealth and Human S · Phase II · TDP-43 aggregation inhibitors for the treatment of ALS$3.4M
- Federal grantHealth and Human S · Phase II · TDP-43 aggregation inhibitors for the treatment of ALS$924K
- Federal grantHealth and Human S · Phase I · TDP-43 aggregation inhibitors for the treatment of ALS$183K
- Federal grantHealth and Human S · Phase I · TDP-43 aggregation inhibitors for the treatment of ALS$682K
- Federal grantHealth and Human S · Phase I · TDP-43 aggregation inhibitors for the treatment of ALS$500K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 514 peers
Line = medianBiotech · Molecule
- Federal grants#104 · top 20%
- Granted patents#186 · top 36%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 1 granted of 28- PendingCompounds, Compositions And Methods Of UseUSPTOApplication 17982187
- GrantedCompounds, Compositions And Methods Of UseUSPTOUS 11,542,233
- PendingCompounds, Compositions And Methods Of Use Against Stress GranulesUSPTOApplication 15767905
Show all 28 patent records
- Compounds, Compositions And Methods Of UseSep 28, 2023 · Application 17982187Pending
- Compounds, Compositions And Methods Of UseJan 3, 2023 · US 11,542,233Granted
- Compounds, Compositions And Methods Of Use Against Stress GranulesOct 25, 2018 · Application 15767905Pending
- Compounds, Compositions And Methods Of UseDec 28, 2017 · Application 15533339Pending
- Compounds, Compositions And Methods Of UseDec 21, 2017 · Application 15533354Pending
- Compounds, Compositions And Methods Of UseApplication PCTUS2024019162Pending
- Compounds For Treatment Of Neurodegenerative DiseasesApplication 63545709Pending
- Compounds, Compositions, And Methods Of UseApplication 63489407Pending
- Compounds, Compositions And Methods Of UseApplication PCTUS2022077670Pending
- Compounds, Compositions And Methods Of UseApplication 63252844Pending
- Compounds, Compositions And Methods Of UseApplication PCTUS2019064356Pending
- Compounds, Compositions And Methods Of UseApplication 62874674Pending
- Compounds, Compositions And Methods Of UseApplication 62775006Pending
- Compounds, Compositions And Methods Of UseApplication PCTUS2018027969Pending
- Compouns, Compositions And Methods Of UseApplication PCTUS2017068186Pending
- Compounds, Compositions And Methods Of UseApplication 62560493Pending
- Compounds, Compositions And Methods Of UseApplication 62487180Pending
- Compounds, Compositions And Methods Of UseApplication 62438836Pending
- Compounds, Compositions And Methods Of UseApplication PCTUS2016057219Pending
- Compounds, Compositions And Methods Of UseApplication PCTUS2015064107Pending
- Compounds, Compositions And Methods Of UseApplication PCTUS2015064103Pending
- Compounds, Compositions And Methods Of UseApplication 16606303Pending
- Inhibitors Of TDP-43 And Tau AggregationApplication 19163007Pending
- Compounds For Treatment Of Neurodegenerative DiseasesApplication 19581598Pending
- Compounds For Treatment Of Neurodegenerative DiseasesApplication PCTUS2025039299Pending
- Compounds For Treatment Of Neurodegenerative DiseasesApplication PCTUS2024053056Pending
- Compounds For Treatment Of Neurodegenerative DiseasesApplication 63676131Pending
- Compounds For Treatment Of Neurodegenerative DiseasesApplication 63676188Pending
Related companies, and why
- Monopar TherapeuticsSimilar federal contract value in Biotech · null in contracts
- STRESS THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
- MPEX PHARMACEUTICALS, INC.Similar federal contract value in Biotech · null in contracts
- Atrapos Therapeutics, LLCSimilar federal contract value in Biotech · null in contracts
- Chimera BioTechnology, Inc.Similar federal contract value in Biotech · null in contracts
- SELSYM BIOTECH INCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .